Literature DB >> 17400273

Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication?

Ying Huang1, Kirk Staschke, Raffaele De Francesco, Seng-Lai Tan.   

Abstract

The hepatitis C virus (HCV) nonstructural 5A (NS5A) phosphoprotein has been intensely studied due to its ability to subvert the host interferon-induced antiviral response. However, more recent studies suggest that it may also play an important regulatory role in HCV RNA replication as well as modulate host intracellular signaling pathways. Phosphorylation of NS5A appears to be a highly regulated process and several cellular protein kinases responsible for NS5A phosphorylation have been identified in vitro. Studies utilizing the HCV replicon cell culture system have suggested a provocative role for the differential phosphorylation of NS5A in the regulation of viral RNA replication through its association with the viral replication complex, including several host cell factors. Importantly, recent in vivo data linking loss of NS5A hyperphosphorylation to non-productive HCV replication in the chimpanzee model have provided high validation for targeting the cellular kinases involved, particularly the kinases responsible for NS5A phosphorylation, for antiviral therapeutic intervention. Understanding the process of NS5A phosphorylation and the definite identification of the culprit cellular protein kinase(s) will shed light on the mechanisms of HCV RNA replication and/or pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400273     DOI: 10.1016/j.virol.2007.01.042

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  67 in total

1.  Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.

Authors:  Shuanghu Liu; Cassie A Nelson; Li Xiao; Ling Lu; Punit P Seth; Darrell R Davis; Curt H Hagedorn
Journal:  Antiviral Res       Date:  2010-11-12       Impact factor: 5.970

Review 2.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

3.  The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly.

Authors:  Tung Phan; Andrew Kohlway; Peniel Dimberu; Anna Marie Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

4.  Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.

Authors:  Raphael Wolfisberg; Kenn Holmbeck; Louise Nielsen; Amit Kapoor; Charles M Rice; Jens Bukh; Troels K H Scheel
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

5.  Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system.

Authors:  Robert A Fridell; Dike Qiu; Chunfu Wang; Lourdes Valera; Min Gao
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

6.  Classical swine fever virus NS5A protein localizes to endoplasmic reticulum and induces oxidative stress in vascular endothelial cells.

Authors:  Lei He; Yan-Ming Zhang; Zhi Lin; Wei-Wei Li; Jing Wang; He-Lin Li
Journal:  Virus Genes       Date:  2012-06-21       Impact factor: 2.332

7.  Computational identification of post-translational modification sites and functional families reveal possible moonlighting role of rotaviral proteins.

Authors:  Shiladitya Chattopadhyay; Parikshit Bagchi; Dipanjan Dutta; Anupam Mukherjee; Nobumichi Kobayashi; Mamta Chawlasarkar
Journal:  Bioinformation       Date:  2010-04-30

8.  Identification of GBV-D, a novel GB-like flavivirus from old world frugivorous bats (Pteropus giganteus) in Bangladesh.

Authors:  Jonathan H Epstein; Phenix-Lan Quan; Thomas Briese; Craig Street; Omar Jabado; Sean Conlan; Shahneaz Ali Khan; Dawn Verdugo; M Jahangir Hossain; Stephen K Hutchison; Michael Egholm; Stephen P Luby; Peter Daszak; W Ian Lipkin
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

Review 9.  Intracellular innate immune cascades and interferon defenses that control hepatitis C virus.

Authors:  Stacy M Horner; Michael Gale
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

10.  Cochaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway.

Authors:  Shuhei Taguwa; Hiroto Kambara; Hiroko Omori; Hideki Tani; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Tamotsu Yoshimori; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.